Influence of IL1B polymorphism on CpG island hypermethylation in Helicobacter pylori-infected gastric cancer.
Helicobacter pylori infection can induce aberrant CpG island hypermethylation in gastric mucosal epithelial cells. Single nucleotide polymorphisms of proinflammatory cytokine genes encoding for interleukin 1B (IL1B), IL6, and IL8 have been demonstrated to be associated with an increased risk of gastric cancer. To identify the influence of host genetic factors in CpG island hypermethylation induced by H. pylori infection, we analyzed H. pylori-infected chronic gastritis (n = 111) and gastric cancer samples (n = 78) for the methylation status of eight genes previously shown to be hypermethylated in chronic gastritis and single nucleotide polymorphisms of IL1B, IL6, and IL8. The methylation levels were then compared between different genotypes. Gastric cancers from patients with the IL1B-511T/T allele showed significantly higher methylation levels in five genes as compared with gastric cancers from IL1B-511 C carriers (P < 0.05). An increased level of hypermethylation in association with the IL1B-511T/T allele was observed in chronic gastritis samples, but the association was not statistically significant. These findings suggest that the IL1B-511T/T allele is associated with enhanced hypermethylation of multiple CpG island loci, which might contribute to an increase in the risk for gastric cancer in individuals with H. pylori infection and IL1B-511T/T allele.
Yoo
Eun Joo
EJ
Laboratory of Epigenetics, Cancer Research Institute, Seoul National University College of Medicine, Seoul, South Korea.
Park
Seog-Yun
SY
Cho
Nam-Yun
NY
Kim
Nayoung
N
Lee
Hye Seung
HS
Kim
Donguk
D
Kang
Gyeong Hoon
GH
D018899:CpG Islands; D019175:DNA Methylation; D005260:Female; D005838:Genotype; D016481:Helicobacter Infections / Q000150:complications*; D016480:Helicobacter pylori; D006801:Humans; D053583:Interleukin-1beta / Q000235:genetics*; D008297:Male; D008875:Middle Aged; D020641:Polymorphism, Single Nucleotide; D013274:Stomach Neoplasms / Q000235:genetics*
D053583:Interleukin-1beta
Virchows Arch. 2008 May;452(5):515-24
18335237
Nat Genet. 1999 Feb;21(2):163-7
9988266
J Biol Chem. 2000 Jun 16;275(24):18138-44
10747905
Nucleic Acids Res. 2000 Apr 15;28(8):E32
10734209
J Biol Chem. 2001 Oct 26;276(43):39508-11
11551897
Nat Genet. 2007 Feb;39(2):232-6
17200670
Cancer Res. 2006 Nov 1;66(21):10517-24
17079474
Int J Cancer. 2005 Apr 10;114(3):465-71
15551344
J Gastroenterol. 1999;34 Suppl 11:10-7
10616759
Nat Genet. 2007 Feb;39(2):157-8
17200673
Clin Cancer Res. 2006 Feb 1;12(3 Pt 1):989-95
16467114
Am J Pathol. 2006 Nov;169(5):1643-51
17071588
Am J Physiol. 1991 Oct;261(4 Pt 1):G559-64
1681735
Lab Invest. 2008 Feb;88(2):161-70
18158559
J Mol Diagn. 2006 May;8(2):209-17
16645207
Clin Cancer Res. 2006 May 15;12(10):3216-21
16707623
Cell. 2006 Apr 21;125(2):301-13
16630818
Nat Genet. 2007 Feb;39(2):237-42
17211412
Eur J Immunogenet. 1998 Apr-Jun;25(2-3):267
9615916
J Exp Med. 1999 Dec 6;190(11):1595-604
10587350
Nature. 2000 Mar 23;404(6776):398-402
10746728
Gut. 2007 Apr;56(4):595-7
17369391
Cancer Epidemiol Biomarkers Prev. 2005 Nov;14(11 Pt 1):2487-93
16284368
Gut. 2006 Apr;55(4):463-8
16428266
Methods. 2001 Dec;25(4):456-62
11846615
Gastroenterology. 2002 Dec;123(6):1793-803
12454835
Am J Gastroenterol. 2007 Jul;102(7):1361-71
17509026
J Gastroenterol. 2006 May;41(5):401-7
16799880
Cancer Res. 2005 Jun 1;65(11):4673-82
15930285
J Clin Invest. 1998 Oct 1;102(7):1369-76
9769329
J Gastroenterol Hepatol. 2007 Feb;22(2):234-9
17295877
Gut. 2003 Apr;52(4):502-6
12631658